APA (7th ed.) Citation

Ding, Y., Zhao, J., Wang, Q., Tian, X., Li, M., & Zeng, X. (2023). LSO-009 The impact of high-risk antiphospholipid antibodies profile on major organ damage progression in systemic lupus erythematosus: CSTAR multiple prospective cohort study. Lupus science & medicine, 10(Suppl 1), A39. https://doi.org/10.1136/lupus-2023-KCR.52

Chicago Style (17th ed.) Citation

Ding, Yufang, Jiuliang Zhao, Qian Wang, Xinping Tian, Mengtao Li, and Xiaofeng Zeng. "LSO-009 The Impact of High-risk Antiphospholipid Antibodies Profile on Major Organ Damage Progression in Systemic Lupus Erythematosus: CSTAR Multiple Prospective Cohort Study." Lupus Science & Medicine 10, no. Suppl 1 (2023): A39. https://doi.org/10.1136/lupus-2023-KCR.52.

MLA (9th ed.) Citation

Ding, Yufang, et al. "LSO-009 The Impact of High-risk Antiphospholipid Antibodies Profile on Major Organ Damage Progression in Systemic Lupus Erythematosus: CSTAR Multiple Prospective Cohort Study." Lupus Science & Medicine, vol. 10, no. Suppl 1, 2023, p. A39, https://doi.org/10.1136/lupus-2023-KCR.52.